RecruitingNot ApplicableNCT06190613

Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria

Adapting and Testing a Combination Peer Navigation and mHealth Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria

Sponsor

Northwestern University

Enrollment

100 participants

Start Date

Nov 28, 2024

Study Type

INTERVENTIONAL

Conditions

HIV

Summary

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.

Eligibility

Sex: MALEMin Age: 15 YearsMax Age: 29 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a combination program to help young gay men and transgender women living with HIV in Nigeria stay engaged with their care and keep their viral load undetectable. **You may be eligible if...** - You are HIV-positive and assigned male at birth - You identify as a young man who has sex with men or as a young transgender woman - You are a registered patient at one of the participating community health centers in Nigeria - You have been on HIV treatment (antiretroviral therapy) for at least 3 months - You have a cellphone - You can read and understand basic English, Yoruba, or Pidgin English **You may NOT be eligible if...** - You are 15 years old and not legally independent, and cannot get parental permission Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCombination Peer navigation and mHealth intervention

Peer navigation and SMS text message medication reminders (adapted to YMSM and YTW in community outreach-based delivery approach)

Locations(1)

University of Ibadan

Ibadan, Nigeria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06190613

Related Trials

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

NCT000012812 locations

Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies

NCT001146471 location

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

NCT054704911 location

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

NCT054190241 location

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

NCT000065181 location